Shopping Cart 0
Cart Subtotal
USD 0

BioSpecifics Technologies Corp (BSTC)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

BioSpecifics Technologies Corp (BSTC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company operations and business divisions.

Corporate strategy-Analyst summarization of the company business strategy.

SWOT Analysis-A detailed analysis of the company strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioSpecifics Technologies Corp (BioSpecifics) is a biopharmaceutical company It has developed injectable collagenase for the treatment of the clinical indications. The company injectable collagenase is marketed as Xiaflex (collagenase clostridium histolyticum or CCH) in the US. Xiaflex is used in the treatment of conditions such as Dupuytren contracture and Peyronie disease. Biospecifics had partnered with Auxilium Pharmaceuticals, Inc. (Auxilium) for the development and marketing of Xiaflex, under this partnership the company has conducted clinical trials of injectable collagenase for the treatment of conditions such as frozen shoulder and cellulite. The company operates through its partners in Canada, Australia, Japan and other European countries. BioSpecifics is headquartered in New York, the US.

BioSpecifics Technologies Corp Key Recent Developments

May 10,2017: BioSpecifics Technologies Reports First Quarter 2017 Financial Results

Mar 15,2017: BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results

Nov 09,2016: BioSpecifics Technologies Reports Third Quarter 2016 Financial Results

Aug 09,2016: BioSpecifics Technologies Corp. Reports Second Quarter 2016 Financial Results

Aug 09,2016: BioSpecifics Technologies Reports Second Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

BioSpecifics Technologies Corp-Key Facts 5

BioSpecifics Technologies Corp-Key Employees 6

BioSpecifics Technologies Corp-Major Products and Services 7

BioSpecifics Technologies Corp-History 8

BioSpecifics Technologies Corp-Company Statement 10

BioSpecifics Technologies Corp-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

BioSpecifics Technologies Corp-Business Description 16

BioSpecifics Technologies Corp-SWOT Analysis 17

SWOT Analysis-Overview 17

BioSpecifics Technologies Corp-Strengths 17

BioSpecifics Technologies Corp-Weaknesses 18

BioSpecifics Technologies Corp-Opportunities 19

BioSpecifics Technologies Corp-Threats 20

BioSpecifics Technologies Corp-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

BioSpecifics Technologies Corp, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

May 10, 2017: BioSpecifics Technologies Reports First Quarter 2017 Financial Results 31

Mar 15, 2017: BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results 33

Nov 09, 2016: BioSpecifics Technologies Reports Third Quarter 2016 Financial Results 35

Aug 09, 2016: BioSpecifics Technologies Corp. Reports Second Quarter 2016 Financial Results 37

Aug 09, 2016: BioSpecifics Technologies Reports Second Quarter 2016 Financial Results 39

May 10, 2016: BioSpecifics Technologies Reports First Quarter 2016 Financial Results 41

Mar 14, 2016: BioSpecifics Technologies Reports Fourth Quarter and Full Year 2015 Financial Results 43

Section 6-Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

BioSpecifics Technologies Corp, Performance Chart (2012-2016) 25

BioSpecifics Technologies Corp, Ratio Charts 27

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29


List Of Table

List of Tables

BioSpecifics Technologies Corp, Key Facts 5

BioSpecifics Technologies Corp, Key Employees 6

BioSpecifics Technologies Corp, Major Products and Services 7

BioSpecifics Technologies Corp, History 8

BioSpecifics Technologies Corp, Subsidiaries 15

BioSpecifics Technologies Corp, Key Competitors 21

BioSpecifics Technologies Corp, Ratios based on current share price 22

BioSpecifics Technologies Corp, Annual Ratios 23

BioSpecifics Technologies Corp, Annual Ratios (Cont...1) 24

BioSpecifics Technologies Corp, Interim Ratios 26

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

BioSpecifics Technologies Corp, Recent Deals Summary 30

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

BioSpecifics Technologies Corp (BSTC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company operations and business divisions.

Corporate strategy-Analyst summarization of the company business strategy.

SWOT Analysis-A detailed analysis of the company strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioSpecifics Technologies Corp (BioSpecifics) is a biopharmaceutical company It has developed injectable collagenase for the treatment of the clinical indications. The company injectable collagenase is marketed as Xiaflex (collagenase clostridium histolyticum or CCH) in the US. Xiaflex is used in the treatment of conditions such as Dupuytren contracture and Peyronie disease. Biospecifics had partnered with Auxilium Pharmaceuticals, Inc. (Auxilium) for the development and marketing of Xiaflex, under this partnership the company has conducted clinical trials of injectable collagenase for the treatment of conditions such as frozen shoulder and cellulite. The company operates through its partners in Canada, Australia, Japan and other European countries. BioSpecifics is headquartered in New York, the US.

BioSpecifics Technologies Corp Key Recent Developments

May 10,2017: BioSpecifics Technologies Reports First Quarter 2017 Financial Results

Mar 15,2017: BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results

Nov 09,2016: BioSpecifics Technologies Reports Third Quarter 2016 Financial Results

Aug 09,2016: BioSpecifics Technologies Corp. Reports Second Quarter 2016 Financial Results

Aug 09,2016: BioSpecifics Technologies Reports Second Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

BioSpecifics Technologies Corp-Key Facts 5

BioSpecifics Technologies Corp-Key Employees 6

BioSpecifics Technologies Corp-Major Products and Services 7

BioSpecifics Technologies Corp-History 8

BioSpecifics Technologies Corp-Company Statement 10

BioSpecifics Technologies Corp-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

BioSpecifics Technologies Corp-Business Description 16

BioSpecifics Technologies Corp-SWOT Analysis 17

SWOT Analysis-Overview 17

BioSpecifics Technologies Corp-Strengths 17

BioSpecifics Technologies Corp-Weaknesses 18

BioSpecifics Technologies Corp-Opportunities 19

BioSpecifics Technologies Corp-Threats 20

BioSpecifics Technologies Corp-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

BioSpecifics Technologies Corp, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

May 10, 2017: BioSpecifics Technologies Reports First Quarter 2017 Financial Results 31

Mar 15, 2017: BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results 33

Nov 09, 2016: BioSpecifics Technologies Reports Third Quarter 2016 Financial Results 35

Aug 09, 2016: BioSpecifics Technologies Corp. Reports Second Quarter 2016 Financial Results 37

Aug 09, 2016: BioSpecifics Technologies Reports Second Quarter 2016 Financial Results 39

May 10, 2016: BioSpecifics Technologies Reports First Quarter 2016 Financial Results 41

Mar 14, 2016: BioSpecifics Technologies Reports Fourth Quarter and Full Year 2015 Financial Results 43

Section 6-Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

BioSpecifics Technologies Corp, Performance Chart (2012-2016) 25

BioSpecifics Technologies Corp, Ratio Charts 27

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29


List Of Table

List of Tables

BioSpecifics Technologies Corp, Key Facts 5

BioSpecifics Technologies Corp, Key Employees 6

BioSpecifics Technologies Corp, Major Products and Services 7

BioSpecifics Technologies Corp, History 8

BioSpecifics Technologies Corp, Subsidiaries 15

BioSpecifics Technologies Corp, Key Competitors 21

BioSpecifics Technologies Corp, Ratios based on current share price 22

BioSpecifics Technologies Corp, Annual Ratios 23

BioSpecifics Technologies Corp, Annual Ratios (Cont...1) 24

BioSpecifics Technologies Corp, Interim Ratios 26

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

BioSpecifics Technologies Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

BioSpecifics Technologies Corp, Recent Deals Summary 30

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com
chat_bubbleLet's Chat